Selected research
Industry Growth & Trends
Global Enzymes for β-lactam Antibiotics Industry Growth and Trends Forecast to 2032
Market perspective
The global Enzymes for β-lactam Antibiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Enzymes for β-lactam Antibiotics include MCE, Amicogen, Biosynth, Crawford Wisdom International, Creative Enzymes, Fermenta Biotech Ltd., Merck & Co., MuseChem Chemicals and Biolab, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Enzymes for β-lactam Antibiotics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Enzymes for β-lactam Antibiotics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Enzymes for β-lactam Antibiotics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Enzymes for β-lactam Antibiotics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Enzymes for β-lactam Antibiotics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Enzymes for β-lactam Antibiotics Market by Company
MCE
Amicogen
Biosynth
Crawford Wisdom International
Creative Enzymes
Fermenta Biotech Ltd.
Merck & Co.
MuseChem Chemicals
Biolab
Hangzhou Chuangke Biotech
Hangzhou Junfeng Bioengineering
Hunan Fulaige Biotech
Shanghai Kekai Biotech
Enzymes for β-lactam Antibiotics Segment by Type
Penicillin Acylase
β-lactamase
Other
Enzymes for β-lactam Antibiotics Segment by Application
Cephalosporins
Penicillin and Its Derivatives
Monoamide Ring
Other
Enzymes for β-lactam Antibiotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzymes for β-lactam Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enzymes for β-lactam Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzymes for β-lactam Antibiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enzymes for β-lactam Antibiotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Enzymes for β-lactam Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Penicillin Acylase
- β-lactamase
- Other
Applications
- Cephalosporins
- Penicillin and Its Derivatives
- Monoamide Ring
- Other
Companies covered
- MCE
- Amicogen
- Biosynth
- Crawford Wisdom International
- Creative Enzymes
- Fermenta Biotech Ltd.
- Merck & Co.
- MuseChem Chemicals
- Biolab
- Hangzhou Chuangke Biotech
- Hangzhou Junfeng Bioengineering
- Hunan Fulaige Biotech
- Shanghai Kekai Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Enzymes for β-lactam Antibiotics Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Enzymes for β-lactam Antibiotics Sales Estimates and Forecasts (2021-2032)
- 1.3 Enzymes for β-lactam Antibiotics Market by Type
- 1.3.1 Penicillin Acylase
- 1.3.2 β-lactamase
- 1.3.3 Other
- 1.4 Global Enzymes for β-lactam Antibiotics Market Size by Type
- 1.4.1 Global Enzymes for β-lactam Antibiotics Market Size Overview by Type (2021-2032)
- 1.4.2 Global Enzymes for β-lactam Antibiotics Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Enzymes for β-lactam Antibiotics Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Enzymes for β-lactam Antibiotics Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Enzymes for β-lactam Antibiotics Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Enzymes for β-lactam Antibiotics Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Enzymes for β-lactam Antibiotics Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Enzymes for β-lactam Antibiotics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Enzymes for β-lactam Antibiotics Industry Trends
- 2.2 Enzymes for β-lactam Antibiotics Industry Drivers
- 2.3 Enzymes for β-lactam Antibiotics Industry Opportunities and Challenges
- 2.4 Enzymes for β-lactam Antibiotics Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Enzymes for β-lactam Antibiotics Revenue (2021-2026)
- 3.2 Global Top Players by Enzymes for β-lactam Antibiotics Sales (2021-2026)
- 3.3 Global Top Players by Enzymes for β-lactam Antibiotics Price (2021-2026)
- 3.4 Global Enzymes for β-lactam Antibiotics Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Enzymes for β-lactam Antibiotics Major Company Production Sites & Headquarters
- 3.6 Global Enzymes for β-lactam Antibiotics Company, Product Type & Application
- 3.7 Global Enzymes for β-lactam Antibiotics Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Enzymes for β-lactam Antibiotics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Enzymes for β-lactam Antibiotics Players Market Share by Revenue in 2025
- 3.8.3 2025 Enzymes for β-lactam Antibiotics Tier 1, Tier 2, and Tier 3
4 Enzymes for β-lactam Antibiotics Regional Status and Outlook
- 4.1 Global Enzymes for β-lactam Antibiotics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Enzymes for β-lactam Antibiotics Historic Market Size by Region
- 4.2.1 Global Enzymes for β-lactam Antibiotics Sales in Volume by Region (2021-2026)
- 4.2.2 Global Enzymes for β-lactam Antibiotics Sales in Value by Region (2021-2026)
- 4.2.3 Global Enzymes for β-lactam Antibiotics Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Enzymes for β-lactam Antibiotics Forecasted Market Size by Region
- 4.3.1 Global Enzymes for β-lactam Antibiotics Sales in Volume by Region (2027-2032)
- 4.3.2 Global Enzymes for β-lactam Antibiotics Sales in Value by Region (2027-2032)
- 4.3.3 Global Enzymes for β-lactam Antibiotics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Enzymes for β-lactam Antibiotics by Application
- 5.1 Enzymes for β-lactam Antibiotics Market by Application
- 5.1.1 Cephalosporins
- 5.1.2 Penicillin and Its Derivatives
- 5.1.3 Monoamide Ring
- 5.1.4 Other
- 5.2 Global Enzymes for β-lactam Antibiotics Market Size by Application
- 5.2.1 Global Enzymes for β-lactam Antibiotics Market Size Overview by Application (2021-2032)
- 5.2.2 Global Enzymes for β-lactam Antibiotics Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Enzymes for β-lactam Antibiotics Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Enzymes for β-lactam Antibiotics Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Enzymes for β-lactam Antibiotics Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Enzymes for β-lactam Antibiotics Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Enzymes for β-lactam Antibiotics Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Enzymes for β-lactam Antibiotics Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 MCE
- 6.1.1 MCE Company Information
- 6.1.2 MCE Business Overview
- 6.1.3 MCE Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 MCE Enzymes for β-lactam Antibiotics Product Portfolio
- 6.1.5 MCE Recent Developments
- 6.2 Amicogen
- 6.2.1 Amicogen Company Information
- 6.2.2 Amicogen Business Overview
- 6.2.3 Amicogen Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Amicogen Enzymes for β-lactam Antibiotics Product Portfolio
- 6.2.5 Amicogen Recent Developments
- 6.3 Biosynth
- 6.3.1 Biosynth Company Information
- 6.3.2 Biosynth Business Overview
- 6.3.3 Biosynth Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Biosynth Enzymes for β-lactam Antibiotics Product Portfolio
- 6.3.5 Biosynth Recent Developments
- 6.4 Crawford Wisdom International
- 6.4.1 Crawford Wisdom International Company Information
- 6.4.2 Crawford Wisdom International Business Overview
- 6.4.3 Crawford Wisdom International Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Crawford Wisdom International Enzymes for β-lactam Antibiotics Product Portfolio
- 6.4.5 Crawford Wisdom International Recent Developments
- 6.5 Creative Enzymes
- 6.5.1 Creative Enzymes Company Information
- 6.5.2 Creative Enzymes Business Overview
- 6.5.3 Creative Enzymes Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Creative Enzymes Enzymes for β-lactam Antibiotics Product Portfolio
- 6.5.5 Creative Enzymes Recent Developments
- 6.6 Fermenta Biotech Ltd.
- 6.6.1 Fermenta Biotech Ltd. Company Information
- 6.6.2 Fermenta Biotech Ltd. Business Overview
- 6.6.3 Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Product Portfolio
- 6.6.5 Fermenta Biotech Ltd. Recent Developments
- 6.7 Merck & Co.
- 6.7.1 Merck & Co. Company Information
- 6.7.2 Merck & Co. Business Overview
- 6.7.3 Merck & Co. Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Merck & Co. Enzymes for β-lactam Antibiotics Product Portfolio
- 6.7.5 Merck & Co. Recent Developments
- 6.8 MuseChem Chemicals
- 6.8.1 MuseChem Chemicals Company Information
- 6.8.2 MuseChem Chemicals Business Overview
- 6.8.3 MuseChem Chemicals Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 MuseChem Chemicals Enzymes for β-lactam Antibiotics Product Portfolio
- 6.8.5 MuseChem Chemicals Recent Developments
- 6.9 Biolab
- 6.9.1 Biolab Company Information
- 6.9.2 Biolab Business Overview
- 6.9.3 Biolab Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Biolab Enzymes for β-lactam Antibiotics Product Portfolio
- 6.9.5 Biolab Recent Developments
- 6.10 Hangzhou Chuangke Biotech
- 6.10.1 Hangzhou Chuangke Biotech Company Information
- 6.10.2 Hangzhou Chuangke Biotech Business Overview
- 6.10.3 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Product Portfolio
- 6.10.5 Hangzhou Chuangke Biotech Recent Developments
- 6.11 Hangzhou Junfeng Bioengineering
- 6.11.1 Hangzhou Junfeng Bioengineering Company Information
- 6.11.2 Hangzhou Junfeng Bioengineering Business Overview
- 6.11.3 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Product Portfolio
- 6.11.5 Hangzhou Junfeng Bioengineering Recent Developments
- 6.12 Hunan Fulaige Biotech
- 6.12.1 Hunan Fulaige Biotech Company Information
- 6.12.2 Hunan Fulaige Biotech Business Overview
- 6.12.3 Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Product Portfolio
- 6.12.5 Hunan Fulaige Biotech Recent Developments
- 6.13 Shanghai Kekai Biotech
- 6.13.1 Shanghai Kekai Biotech Company Information
- 6.13.2 Shanghai Kekai Biotech Business Overview
- 6.13.3 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Product Portfolio
- 6.13.5 Shanghai Kekai Biotech Recent Developments
7 North America by Country
- 7.1 North America Enzymes for β-lactam Antibiotics Sales by Country
- 7.1.1 North America Enzymes for β-lactam Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Enzymes for β-lactam Antibiotics Sales by Country (2021-2026)
- 7.1.3 North America Enzymes for β-lactam Antibiotics Sales Forecast by Country (2027-2032)
- 7.2 North America Enzymes for β-lactam Antibiotics Market Size by Country
- 7.2.1 North America Enzymes for β-lactam Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Enzymes for β-lactam Antibiotics Market Size by Country (2021-2026)
- 7.2.3 North America Enzymes for β-lactam Antibiotics Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Enzymes for β-lactam Antibiotics Sales by Country
- 8.1.1 Europe Enzymes for β-lactam Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Enzymes for β-lactam Antibiotics Sales by Country (2021-2026)
- 8.1.3 Europe Enzymes for β-lactam Antibiotics Sales Forecast by Country (2027-2032)
- 8.2 Europe Enzymes for β-lactam Antibiotics Market Size by Country
- 8.2.1 Europe Enzymes for β-lactam Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Enzymes for β-lactam Antibiotics Market Size by Country (2021-2026)
- 8.2.3 Europe Enzymes for β-lactam Antibiotics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Enzymes for β-lactam Antibiotics Sales by Country
- 9.1.1 Asia-Pacific Enzymes for β-lactam Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Enzymes for β-lactam Antibiotics Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Enzymes for β-lactam Antibiotics Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Enzymes for β-lactam Antibiotics Market Size by Country
- 9.2.1 Asia-Pacific Enzymes for β-lactam Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Enzymes for β-lactam Antibiotics Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Enzymes for β-lactam Antibiotics Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Enzymes for β-lactam Antibiotics Sales by Country
- 10.1.1 South America Enzymes for β-lactam Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Enzymes for β-lactam Antibiotics Sales by Country (2021-2026)
- 10.1.3 South America Enzymes for β-lactam Antibiotics Sales Forecast by Country (2027-2032)
- 10.2 South America Enzymes for β-lactam Antibiotics Market Size by Country
- 10.2.1 South America Enzymes for β-lactam Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Enzymes for β-lactam Antibiotics Market Size by Country (2021-2026)
- 10.2.3 South America Enzymes for β-lactam Antibiotics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Enzymes for β-lactam Antibiotics Sales by Country
- 11.1.1 Middle East and Africa Enzymes for β-lactam Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Enzymes for β-lactam Antibiotics Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Enzymes for β-lactam Antibiotics Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Enzymes for β-lactam Antibiotics Market Size by Country
- 11.2.1 Middle East and Africa Enzymes for β-lactam Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Enzymes for β-lactam Antibiotics Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Enzymes for β-lactam Antibiotics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Enzymes for β-lactam Antibiotics Value Chain Analysis
- 12.1.1 Enzymes for β-lactam Antibiotics Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Enzymes for β-lactam Antibiotics Production Mode & Process
- 12.2 Enzymes for β-lactam Antibiotics Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Enzymes for β-lactam Antibiotics Distributors
- 12.2.3 Enzymes for β-lactam Antibiotics Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst